CDSS

US Clinical Decision Support System Market Report 2022: Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency and Improve the Patient Journey - ResearchAndMarkets.com

Retrieved on: 
Friday, April 15, 2022
Health, General Health, Health information management, CDS, CDSS, POC, Workflow, EHR, Laika (EHR testing framework), Solution

The "US Clinical Decision Support System (CDSS) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Clinical Decision Support System (CDSS) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert.
  • This report reviews the growth opportunities that are driving the US CDSS market.
  • The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.

US Clinical Decision Support System Report 2022: Case Studies of Change Healthcare (Payer/Provider Ecosystem) and Wolters Kluwer (Building an End-to-End Solution in a Patient-centric Model)

Retrieved on: 
Wednesday, April 13, 2022
Health information management, CDS, CDSS, POC, Workflow, EHR, Laika (EHR testing framework), Solution

DUBLIN, April 13, 2022 /PRNewswire/ -- The "US Clinical Decision Support System (CDSS) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 13, 2022 /PRNewswire/ -- The "US Clinical Decision Support System (CDSS) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert.
  • This report reviews the growth opportunities that are driving the US CDSS market.
  • The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.

Global Clinical Decision Support Systems Market to 2027 - by Component, Product, Delivery Mode, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 16, 2022
Technology, Health, Data Management, Other Health, Code, Solution, Risk, CVD, Patient, Conditional sentence, Hospital, Knowledge, COVID-19, Pregnancy, Adoption, CAGR, Government, Laika (EHR testing framework), EHR, Application, Hypertension, Behavior, Genetics, Computer, Growth, Data, Hyperlipidemia, Ageing, Medicine, Disease, Health information management, Medical device, CDSS

The "Global Clinical Decision Support Systems Market By Component, By Product, By Delivery Mode, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Decision Support Systems Market By Component, By Product, By Delivery Mode, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Decision Support Systems Market size is expected to reach $8.2 billion by 2027, rising at a market growth of 10.7% CAGR during the forecast period.
  • In industrialized regions, demand for decision assistance based on factual evidence and real-time knowledge has increased at a quicker adoption rate.
  • In a variety of areas, clinical decision support systems encounter significant technical obstacles.

Clinical Decision Support Systems Market Size Worth $8.60 Billion by 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, February 16, 2022
Type 2, CDSS, Adoption, Allergy, EHR, EHRC, Government, Integration, Triage, Solution, SAN, Component, Stand-alone, Technology, Telehealth, Application, LTD, Roger Hawkins (drummer), USD, Revenue, Physician, Growth, Diagnosis, COVID-19, CAGR, Healthcare, Video game, Retail, Pharmaceutical industry

SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc.
  • Surging demand for quality care is one of the primary factors driving the market for clinical decision support systems (CDSS).
  • Read 150-page market research report, " Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2021 - 2028 ", published by Grand View Research.
  • Grand View Research has segmented the global clinical decision support systems market on the basis of product, application, delivery mode, component, and region:
    Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

Clinical Decision Support Systems Market Size Worth $8.60 Billion by 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, February 16, 2022
Type 2, CDSS, Adoption, Allergy, EHR, EHRC, Government, Integration, Triage, Solution, SAN, Component, Stand-alone, Technology, Telehealth, Application, LTD, Roger Hawkins (drummer), USD, Revenue, Physician, Growth, Diagnosis, COVID-19, CAGR, Healthcare, Video game, Retail, Pharmaceutical industry

SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc.
  • Surging demand for quality care is one of the primary factors driving the market for clinical decision support systems (CDSS).
  • Read 150-page market research report, " Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2021 - 2028 ", published by Grand View Research.
  • Grand View Research has segmented the global clinical decision support systems market on the basis of product, application, delivery mode, component, and region:
    Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

Nuvo Group Presents New Data Supporting Expanded Capability of INVU™ Platform for Remote High-Risk Pregnancy Monitoring at Society of Maternal Fetal Medicine's 42nd Annual Pregnancy Meeting

Retrieved on: 
Thursday, February 3, 2022
Perelman School of Medicine at the University of Pennsylvania, Pregnancy, Patient, Parent, Workflow, Nuvo, University, INVU, MD, Contraindication, Machine learning, American Journal of Obstetrics and Gynecology, Technology, Academic health science centre, Maternal–fetal medicine, CDSS, Woman, Research, Obstetrics, CB Insights, Society, Fast Company, Uterine contraction, Digital, AJOG, Society for Maternal-Fetal Medicine, Industry, NST, FDA, Multimedia, TEL, American Journal, Medical imaging, Medicine, Birth control, Gynaecology

TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ --Nuvo Group, a leader in modern maternal-fetal health, today presented new clinical data for INVUTM , the only FDA-cleared, prescription-initiated, remote pregnancy monitoring and management platform, at the Society for Maternal Fetal Medicine (SMFM)'s 42nd Annual Pregnancy Meeting.

Key Points: 
  • TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ --Nuvo Group, a leader in modern maternal-fetal health, today presented new clinical data for INVUTM , the only FDA-cleared, prescription-initiated, remote pregnancy monitoring and management platform, at the Society for Maternal Fetal Medicine (SMFM)'s 42nd Annual Pregnancy Meeting.
  • INVU safely and accurately shifts the point of care and frees up time for both the doctor and the patient.
  • "Taken together, these capabilities have the potential to significantly improve pregnancy care for both the clinical care team and expectant mothers."
  • For more information and complete indications, contraindications, warnings and precautions along with instructions for use, visit: www.nuvocares.com .

Coriell Life Sciences Achieves HITRUST CSF® Certification for GeneDose Live Clinical Decision Support System

Retrieved on: 
Monday, January 10, 2022
Technology, Precision medicine, CLS, Population, Safety, CDSS, CEO, DNA, Health, Industry, HITRUST, Certification, Compliance, Organization, Physician, Risk, Pharmaceutical industry, Management

PHILADELPHIA, Jan. 10, 2022 /PRNewswire/ -- With a steadfast commitment to protectingpersonal healthcare information, Coriell Life Sciences (CLS) a leader in precision medicine dedicated to personalized medication safety is proud to announce its GeneDose Live clinical decision support system (CDSS) has earned Certified status for information security by HITRUST.

Key Points: 
  • PHILADELPHIA, Jan. 10, 2022 /PRNewswire/ -- With a steadfast commitment to protectingpersonal healthcare information, Coriell Life Sciences (CLS) a leader in precision medicine dedicated to personalized medication safety is proud to announce its GeneDose Live clinical decision support system (CDSS) has earned Certified status for information security by HITRUST.
  • "Achieving HITRUST Certification is a testament to the fact that Coriell Life Sciences is using highly advanced and highly secure technology to enable the most precise medical care,"says Scott Megill, President & CEO of Coriell Life Sciences.
  • "Coriell Life Sciences' HITRUST CSF Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance."
  • Coriell Life Sciences (CLS), a leader in genetic science, uses innovation in precision medicine to reduce healthcare costs and empower a healthier world.

Global Clinical Decision Support Systems (Standalone CDSS, Integrated EHR With CDSS) Market Research Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 4, 2022
General Health, Health, Data Management, Technology, Software, EHR, COVID-19, CAGR, Government, Growth, Type 2, Physician, Telehealth, Roger Hawkins (drummer), Integration, EHRC, CDSS, LTD, Triage, Diagnosis, Adoption, Technology, Component, Solution, Stand-alone, Pharmaceutical industry

The "Global Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR With CDSS), Application, Delivery Mode, Component, Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR With CDSS), Application, Delivery Mode, Component, Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • Surging demand for quality care is one of the primary factors driving the market for clinical decision support systems (CDSS).
  • The growing interest in enhanced medical care and efficient decision-making is projected to fuel the adoption of CDSS and EHR.
  • To manage the COVID-19 pandemic, many initiatives are being undertaken by the government and community organizations to support the current healthcare system.

Netsmart and American Society of Addiction Medicine Announce Partnership to Integrate ASAM CONTINUUM System

Retrieved on: 
Monday, November 15, 2021
Data Management, Health, Technology, Telecommunications, Mobile, Wireless, Software, General Health, Society, Laika (EHR testing framework), Software as a service, Addiction medicine, III, Counselor, Tic disorder, American Society of Addiction Medicine, Â, Face, Research, Facebook, Law enforcement, YouTube, Partnership, CONTINUUM, ASAM, CDSS, Twitter, Health information management, Serving His Children, Netsmart Technologies, LinkedIn, Solution, Physician, Human services, Patient, City centre, EHR, Pharmaceutical industry, Public relations, Medicine, ASAM, Netsmart, ASAM, NETSMART

Netsmart , an industry-leading provider of healthcare technology solutions and services, today announced a strategic partnership with the American Society of Addiction Medicine (ASAM) to integrate the ASAM CONTINUUM and ASAM CO-Triage assessment tools within the Netsmart electronic health record (EHR) platform.

Key Points: 
  • Netsmart , an industry-leading provider of healthcare technology solutions and services, today announced a strategic partnership with the American Society of Addiction Medicine (ASAM) to integrate the ASAM CONTINUUM and ASAM CO-Triage assessment tools within the Netsmart electronic health record (EHR) platform.
  • The partnership will improve the accessibility and quality of care for individuals with addiction and co-occurring disorders across the nation.
  • Netsmart is one of the top electronic health record providers for addiction treatment and behavioral health practice management, said William F. Haning, III, MD, DLFAPA, DFASAM, president of ASAM.
  • ASAM, founded in 1954, is a professional medical society representing over 6,600 physicians, clinicians, and associated professionals in the field of addiction medicine.

Frost & Sullivan recognizes Change Healthcare with the 2021 North America Customer Value Leadership Award for Clinical Decision Support

Retrieved on: 
Tuesday, September 28, 2021
Adoption, Probability, Artificial intelligence, Compliance, Social Security Amendments of 1965, Health information management, Achievement, Solution, Length of stay, Protecting Access to Medicare Act of 2014, Frost & Sullivan, Patient, Frost, CMS, Autoreview, Leadership, EHR, Change Healthcare, PAMA, CDS, Automation, CDSS, Health care, Machine learning, Literature, Natural language processing, Breast cancer, Industry, Medicine

SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Based on its recent analysis of the North American clinical decision support system (CDSS) market, Frost & Sullivan recognizes Change Healthcare with the 2021 North America Customer Value Leadership Award. Its CDSS InterQual® and CareSelect® solutions provide self-built and third-party, evidence-based guidelines that aid providers and payers in decision-making. Powered by advanced technology combining predictive analytics, machine learning, robotic process automation and natural language processing, its CDSS leverages artificial intelligence to advance value-based care and improve payer-provider communications.

Key Points: 
  • Change Healthcare's CDS solutions improve efficiencies, lower unnecessary costly interventions, and deliver measurable positive outcomes, driving customer trust and a high growth rate
    SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ --Based on its recent analysis of the North American clinical decision support system (CDSS) market, Frost & Sullivan recognizes Change Healthcare with the 2021 North America Customer Value Leadership Award.
  • "Change Healthcare's CDSS validates care and order appropriateness, drives cost- and resource-optimized clinical decisions, and standardizes and streamlines care decision workflows.
  • It integrates clinical criteria, electronic health records data, and the care management system's foundation to ensure seamless payer and provider connectivity," said Unmesh Lal, Director at Frost & Sullivan.
  • The award recognizes the company's unique focus on augmenting the value that its customers receive, beyond simply good customer service, leading to improved customer retention and customer base expansion.